Transcutaneous Cervical Vagus Nerve Stimulation Modulates Prefrontal Cortex Activity During Opioid Withdrawal in Individuals With Opioid Use Disorder
- PMID: 40548916
- PMCID: PMC12400781
- DOI: 10.1016/j.neurom.2025.04.012
Transcutaneous Cervical Vagus Nerve Stimulation Modulates Prefrontal Cortex Activity During Opioid Withdrawal in Individuals With Opioid Use Disorder
Abstract
Background: Opioid use disorder (OUD) is associated with considerable morbidity and mortality with limited treatment approaches. Understanding brain mechanisms in response to treatment could be useful in guiding future developments in treatment approaches.
Objective: The purpose of this study was to assess the effects of transcutaneous cervical vagus nerve stimulation (tcVNS) on brain response to opioid use cues in patients with OUD in opioid withdrawal.
Materials and methods: Patients with OUD who were in the early stage of recovery and/or on medication underwent brain imaging with positron emission tomography and radiolabeled water in conjunction with stimulation with active tcVNS or sham devices and exposure to opioid-use-related cues.
Results: tcVNS caused a relative increase in function in the anterior cingulate, dorsal anterior cingulate, and left inferior frontal gyrus during exposure to opioid cues. There also was a pattern of increased activation in the ventral striatum and orbitofrontal cortex.
Conclusion: tcVNS modulates brain areas implicated in opioid addiction, suggesting a useful role as an adjunctive therapy for OUD.
Clinical trial registration: The Clinicaltrials.gov registration number for the study is NCT04556552.
Keywords: Noninvasive; opioid use disorder; prefrontal cortex; vagus nerve stimulation.
Copyright © 2025 International Neuromodulation Society. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest James Douglas Bremner reports equipment, drugs, or supplies were provided by electroCore LLC (tcVNS and sham devices). The remaining authors reported no conflict of interest.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Proactive Addiction Consultation for Hospitalized Patients With Opioid Use Disorder: A Pilot Study.J Acad Consult Liaison Psychiatry. 2025 Jul-Aug;66(4):311-319. doi: 10.1016/j.jaclp.2025.04.002. Epub 2025 Apr 25. J Acad Consult Liaison Psychiatry. 2025. PMID: 40288650 Clinical Trial.
-
Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal.JAMA Netw Open. 2024 Jul 1;7(7):e2420702. doi: 10.1001/jamanetworkopen.2024.20702. JAMA Netw Open. 2024. PMID: 38976265 Free PMC article. Clinical Trial.
-
Vagus nerve stimulation for partial seizures.Cochrane Database Syst Rev. 2015 Apr 3;2015(4):CD002896. doi: 10.1002/14651858.CD002896.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2022 Jul 14;7:CD002896. doi: 10.1002/14651858.CD002896.pub3. PMID: 25835947 Free PMC article. Updated.
-
Evaluating comparative effectiveness of psychosocial interventions adjunctive to opioid agonist therapy for opioid use disorder: A systematic review with network meta-analyses.PLoS One. 2020 Dec 28;15(12):e0244401. doi: 10.1371/journal.pone.0244401. eCollection 2020. PLoS One. 2020. PMID: 33370393 Free PMC article.
References
-
- U.S. overdose deaths decrease in 2023, first time since 2018. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2024/20240515.htm; 2024. Accessed July 22, 2024.
-
- Spencer MR, Garnett M, Miniño AM. Drug overdose deaths in the United States, 2002–2022. US Department of Health and Human Services, Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/products/databriefs/db491.htm. Accessed July 22, 2024.
-
- FastStats. Centers for Disease Control and Prevention. https://web.archive.org/web/20240719122325/. Accessed July 22, 2024.
-
- Korf J, Bunney BS, Aghajanian GK. Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol. 1974;25:165–169. - PubMed
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical